Home > Cashflow Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹-6.74 Cr₹-6.29 Cr₹4.11 Cr₹13 Cr₹13 Cr

What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?

The latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH is ₹-6.74 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹-6.74 Cr
Mar2023₹-6.29 Cr
Mar2022₹4.11 Cr
Mar2021₹13 Cr
Mar2020₹13 Cr

How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹-6.74 Cr
Negative
Mar2023 ₹-6.29 Cr
Negative
Mar2022 ₹4.11 Cr
-67.83
Mar2021 ₹13 Cr
-0.23
Mar2020 ₹13 Cr -

Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹529.2 Cr -3.2% -8.2% -13.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-3.2%

-8.2%

-13.1%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses